SARS-CoV2 vaccines: Slow is fast
Open Access
- 10 July 2020
- journal article
- editorial
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 6 (28), eabc7428
- https://doi.org/10.1126/sciadv.abc7428
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Rapid development of an inactivated vaccine for SARS-CoV-2Published by Cold Spring Harbor Laboratory ,2020
- Anti–spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infectionJCI Insight, 2019
- Pathogenesis of oral type I feline infectious peritonitis virus (FIPV) infection: Antibody-dependent enhancement infection of cats with type I FIPV via the oral routeThe Journal of Veterinary Medical Science, 2019
- Dengvaxia sensitizes seronegatives to vaccine enhanced disease regardless of ageVaccine, 2017
- Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteinsBiochemical and Biophysical Research Communications, 2014
- Anti-Severe Acute Respiratory Syndrome Coronavirus Spike Antibodies Trigger Infection of Human Immune Cells via a pH- and Cysteine Protease-Independent FcγR PathwayJournal of Virology, 2011
- Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcγRII-dependent entry into B cells in vitroVaccine, 2007
- Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunityProceedings of the National Academy of Sciences of the United States of America, 2004
- Antibody‐dependent enhancement of viral infection: molecular mechanisms and in vivo implicationsReviews in Medical Virology, 2003
- A study on the mechanism of antibody-dependent enhancement of feline infectious peritonitis virus infection in feline macrophages by monoclonal antibodiesArchiv für die gesamte Virusforschung, 1991